Congestive Heart Failure Treatment Device Market 2025 by Types, Application, Technology, Opportunities, End Users and Regions | The Insight Partners

Congestive Heart Failure Treatment Device Market - Global Analysis and Forecast By Product (Ventricular Assist Devices, Counter Pulsation Devices, Implantable Cardioverter Defibrillators, Pacemakers, Cardiac Resynchronization Therapy) By End User (Hospitals, Ambulatory Care Centers and Others) and Geography

Report Code: TIPHE100001291 | No. of Pages: 150 | Category: Medical Device | Status: Upcoming

Congestive heart failure (CHF) is a condition that affects the ability of the heart muscles to pump sufficient amount of blood. This condition results in shortness of breath, excessive tiredness, and leg swelling. Therefore, it is important to manage heart failure with the help of various devices such as defibrillators, pacemakers available in the market.

Congestive heart failure (CHF) treatment devices market is mainly driven by rising prevalence of cardiovascular diseases, technological advancements, and increasing number of cardiovascular surgeries. Additionally, positive reimbursement policies for cardiovascular related surgeries and operations are likely to add new opportunities for this market in the coming years.

The “Global Congestive Heart Failure (CHF) Treatment Devices Market Analysis to 2025” is a specialized and in-depth study of the congestive heart failure (CHF) treatment devices industry with a focus on the global market trend. The report aims to provide an overview of global congestive heart failure (CHF) treatment devices market with detailed market segmentation by product, end user and geography. The global congestive heart failure (CHF) treatment devices market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading market players and offers key trends and opportunities in the market.

On the basis of product, the market is segmented into ventricular assist devices (VADs), pacemakers, counter pulsation devices and cardiac resynchronization therapy. On the basis of end user, the market is segmented into hospitals, ambulatory surgical centers and others.

The report provides a detailed overview on the industry including both qualitative and quantitative information. It provides overview and forecast of the global congestive heart failure (CHF) treatment devices market based on product and end user. It also provides market size and forecast till 2025 for overall congestive heart failure (CHF) treatment devices market with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 13 countries globally along with current trend and opportunities prevailing in the region.

North America holds the largest market share in the market owing to extensive use of medical devices for the management of various cardiovascular diseases and rising emphasis on early diagnosis and treatment of cardiovascular disease. However, Asia Pacific is expected to exhibit tremendous growth opportunities due to the presence of huge patient population and rising awareness about the treatments available for cardiovascular diseases.

The report analyzes factors affecting market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the market in these regions.

The report also includes the profiles of key congestive heart failure (CHF) treatment device manufacturing companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, products and services offered, financial information of last three years, key development in past five years. Some of the key players influencing the market are Medtronic, Boston Scientific Corporation, Biotronik, St. Jude Medical, Micromed AS, LivaNova, ABIOMED, HeartWare International, Inc., Jarvik Heart, Inc., Berlin Heart and others.




 

1. INTRODUCTION
1.1. SCOPE OF STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE

2. KEY TAKEAWAYS

3. CONGESTIVE HEART FAILURE (CHF) TREATMENT DEVICES MARKET LANDSCAPE
3.1. MARKET OVERVIEW
3.2. MARKET SEGMENTATION
3.2.1. Congestive Heart Failure (CHF) Treatment Devices market – by Product
3.2.2. Congestive heart failure (CHF) Treatment Devices market – by End User
3.2.3. Congestive Heart Failure (CHF) Treatment Devices market – by Region
3.2.3.1. Congestive Heart Failure (CHF) Treatment Devices Market - By Country
3.3. PEST ANALYSIS
3.3.1. North America – PEST Analysis
3.3.2. Europe – PEST Analysis
3.3.3. Asia Pacific – PEST Analysis
3.3.4. Middle East and Africa – PEST Analysis
3.3.5. South and Central America– PEST Analysis

4. CONGESTIVE HEART FAILURE (CHF) TREATMENT DEVICES MARKET – KEY INDUSTRY DYNAMICS
4.1. KEY MARKET DRIVERS
4.2. KEY MARKET RESTRAINTS
4.3. KEY MARKET OPPORTUNITIES
4.4. FUTURE TRENDS
4.5. IMPACT ANALYSIS

5. CONGESTIVE HEART FAILURE (CHF) TREATMENT DEVICES MARKET – GLOBAL ANALYSIS
5.1. GLOBAL CONGESTIVE HEART FAILURE (CHF) TREATMENT DEVICES MARKET OVERVIEW
5.2. GLOBAL CONGESTIVE HEART FAILURE (CHF) TREATMENT DEVICES MARKET REVENUE FORECASTS AND ANALYSIS (US$ MN)
5.3. GLOBAL CONGESTIVE HEART FAILURE (CHF) TREATMENT DEVICES MARKET VOLUME FORECASTS AND ANALYSIS (‘000 UNITS)
5.4. MARKET POSITIONING/MARKET SHARE
5.5. PERFORMANCE OF KEY PLAYERS
5.6. EXPERT OPINIONS

6. CONGESTIVE HEART FAILURE (CHF) TREATMENT DEVICES MARKET- GLOBAL REGULATORY SCENARIO
6.1. OVERVIEW
6.2. NORTH AMERICA
6.3. EUROPE
6.4. ASIA PACIFIC
6.5. MIDDLE EAST & AFRICA
6.6. SOUTH AND CENTRAL AMERICA

7. CONGESTIVE HEART FAILURE (CHF) TREATMENT DEVICES MARKET REVENUE AND FORECASTS TO 2025 – BY PRODUCT
7.1. OVERVIEW
7.2. PRODUCT MARKET REVENUE AND FORECASTS ANALYSIS (US$ MN)
7.3. VENTRICULAR ASSIST DEVICES (VADS) MARKET
7.3.1. Overview
7.3.2. Ventricular Assist Devices (VADS) Market Revenue Forecasts and Analysis (US$ Mn)
7.3.3. Ventricular Assist Devices (VADS) Market Volume Forecasts and Analysis (‘000 Units)
7.3.4. Left Ventricular Assist Devices (LVADS) Market
7.3.4.1. Overview
7.3.4.2. Left Ventricular Assist Devices (LVADs) Market Revenue Forecasts and Analysis (US$ Mn)
7.3.4.3. Left Ventricular Assist Devices (LVADs) Market Volume Forecasts and Analysis (‘000 Units)
7.3.5. Right Ventricular Assist Devices (RVADS) Market
7.3.5.1. Overview
7.3.5.2. Right Ventricular Assist Devices (RVADs) Market Revenue Forecasts and Analysis (US$ Mn)
7.3.5.3. Right Ventricular Assist Devices (RVADs) Market Volume Forecasts and Analysis (‘000 Units)
7.3.6. Biventricular Assist Devices (BIVADS) Market
7.3.6.1. Overview
7.3.6.2. Biventricular Assist Devices (BIVADS) Market Revenue Forecasts and Analysis (US$ Mn)
7.3.6.3. Biventricular Assist Devices (BIVADS) Market Volume Forecasts and Analysis (‘000 Units)
7.4. COUNTER PULSATION DEVICES MARKET
7.4.1. Overview
7.4.2. Counter Pulsation Devices Market Revenue Forecasts and Analysis (US$ Mn)
7.4.3. Counter Pulsation Devices Market Volume Forecasts and Analysis (‘000 Units)
7.5. IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET
7.5.1. Overview
7.5.2. Implantable Cardioverter Defibrillators Market Revenue Forecasts and Analysis (US$ Mn)
7.5.3. Implantable Cardioverter Defibrillators Market Volume Forecasts and Analysis (‘000 Units)
7.5.4. Transvenous ICD Market
7.5.4.1. Overview
7.5.4.2. Transvenous ICD Market Revenue Forecasts and Analysis (US$ Mn)
7.5.4.3. Transvenous ICD Market Volume Forecasts and Analysis (‘000 Units)
7.5.5. Subcutaneous ICD Market
7.5.5.1. Overview
7.5.5.2. Subcutaneous ICD Market Revenue Forecasts and Analysis (US$ Mn)
7.5.5.3. Subcutaneous ICD Market Volume Forecasts and Analysis (‘000 Units)
7.6. PACEMAKERS MARKET
7.6.1. Overview
7.6.2. Pacemakers Market Revenue Forecasts and Analysis (US$ Mn)
7.6.3. Pacemakers Market Volume Forecasts and Analysis (‘000 Units)
7.6.4. Implantable Market
7.6.4.1. Overview
7.6.4.2. Implantable Market Revenue Forecasts and Analysis (US$ Mn)
7.6.4.3. Implantable Market Volume Forecasts and Analysis (‘000 Units)
7.6.5. External Market
7.6.5.1. Overview
7.6.5.2. External Market Revenue Forecasts and Analysis (US$ Mn)
7.6.5.3. External Market Volume Forecasts and Analysis (‘000 Units)
7.7. CARDIAC RESYNCHRONIZATION THERAPY MARKET
7.7.1. Overview
7.7.2. Cardiac Resynchronization Therapy Market Revenue Forecasts and Analysis (US$ Mn)
7.7.3. Cardiac Resynchronization Therapy Market Volume Forecasts and Analysis (‘000 Units)
7.7.4. Cardiac Resynchronization Therapy-Defibrillators (CRT-D) Market
7.7.4.1. Overview
7.7.4.2. Cardiac Resynchronization Therapy-Defibrillators (CRT-D) Market Revenue Forecasts and Analysis (US$ Mn)
7.7.4.3. Cardiac Resynchronization Therapy-Defibrillators (CRT-D) Market Volume Forecasts and Analysis (‘000 Units)
7.7.5. Cardiac Resynchronization Therapy-Pacemakers (CRT-P) Market
7.7.5.1. Overview
7.7.5.2. Cardiac Resynchronization Therapy-Pacemakers (CRT-P) Market Revenue Forecasts and Analysis (US$ Mn)
7.7.5.3. Cardiac Resynchronization Therapy-Pacemakers (CRT-P) Market Volume Forecasts and Analysis (‘000 Units)

8. CONGESTIVE HEART FAILURE (CHF) TREATMENT DEVICES MARKET REVENUE AND FORECASTS TO 2025 – BY END USER
8.1. OVERVIEW
8.2. END USER MARKET REVENUE AND FORECASTS ANALYSIS (US$ MN)
8.3. HOSPITALS MARKET
8.3.1. Overview
8.3.2. Hospitals Market Revenue Forecasts and Analysis (Us$ Mn)
8.4. AMBULATORY SURGICAL CENTERS MARKET
8.4.1. Overview
8.4.2. Ambulatory Surgical Centers Market Revenue Forecasts and Analysis (Us$ Mn)
8.5. OTHER END USERS MARKET
8.5.1. Overview
8.5.2. Other End Users Market Revenue Forecasts and Analysis (Us$ Mn)

9. NORTH AMERICA CONGESTIVE HEART FAILURE (CHF) TREATMENT DEVICES MARKET REVENUE AND FORECASTS TO 2025 – COUNTRY ANALYSIS
9.1. NORTH AMERICA CONGESTIVE HEART FAILURE (CHF) TREATMENT DEVICES MARKET OVERVIEW
9.2. NORTH AMERICA CONGESTIVE HEART FAILURE (CHF) TREATMENT DEVICES MARKET REVENUE FORECASTS AND ANALYSIS (US$ MN)
9.3. NORTH AMERICA CONGESTIVE HEART FAILURE (CHF) TREATMENT DEVICES MARKET VOLUME FORECASTS AND ANALYSIS (‘000 UNITS)
9.4. NORTH AMERICA CONGESTIVE HEART FAILURE (CHF) TREATMENT DEVICES MARKET REVENUE AND FORECASTS ANALYSIS – BY PRODUCT (US$ MN)
9.5. NORTH AMERICA CONGESTIVE HEART FAILURE (CHF) TREATMENT DEVICES MARKET VOLUME AND FORECASTS ANALYSIS – BY PRODUCT (‘000 UNITS)
9.5.1. North America Ventricular Assist Devices (VADS) Market Revenue and Forecasts Analysis – By Type (US$ Mn)
9.5.2. North America Ventricular Assist Devices (VADS) Market Volume and Forecasts Analysis – By Type (‘000 Units)
9.5.3. North America Implantable Cardioverter Defibrillators Market Revenue and Forecasts Analysis – By Type (US$ Mn)
9.5.4. North America Implantable Cardioverter Defibrillators Market Volume and Forecasts Analysis – By Type (‘000 Units)
9.5.5. North America Pacemakers Market Revenue and Forecasts Analysis – By Type (Us$ Mn)
9.5.6. North America Pacemakers Market Volume and Forecasts Analysis – By Type (‘000 Units)
9.5.7. North America Cardiac Resynchronization Therapy Market Revenue and Forecasts Analysis – By Type (Us$ Mn)
9.5.8. North America Cardiac Resynchronization Therapy Market Volume and Forecasts Analysis – By Type (‘000 Units)
9.6. NORTH AMERICA CONGESTIVE HEART FAILURE (CHF) TREATMENT DEVICES MARKET REVENUE AND FORECASTS ANALYSIS – BY END USER (US$ MN)
9.7. NORTH AMERICA CONGESTIVE HEART FAILURE (CHF) TREATMENT DEVICES MARKET REVENUE AND FORECASTS ANALYSIS – BY COUNTRY (US$ MN)
9.8. US MARKET OVERVIEW
9.8.1. US Congestive Heart Failure (CHF) Treatment Devices Market Revenue Forecasts and Analysis - By Product (US$ Mn)
9.8.2. US Congestive Heart Failure (CHF) Treatment Devices Market Volume Forecasts and Analysis - By Product (‘000 Units)
9.8.2.1. US Ventricular Assist Devices (VADs) Market Revenue and Forecasts Analysis – By Type (US$ Mn)
9.8.2.2. US Ventricular Assist Devices (VADs) Market Volume and Forecasts Analysis – By Type (‘000 Units)
9.8.2.3. US Implantable Cardioverter Defibrillators Market Revenue and Forecasts Analysis – By Type (US$ Mn)
9.8.2.4. US Implantable Cardioverter Defibrillators Market Volume and Forecasts Analysis – By Type (‘000 Units)
9.8.2.5. US Pacemakers Market Revenue and Forecasts Analysis – By Type (US$ Mn)
9.8.2.6. US Pacemakers Market Volume and Forecasts Analysis – By Type (‘000 Units)
9.8.2.7. US Cardiac Resynchronization Therapy Market Revenue and Forecasts Analysis – By Type (US$ Mn)
9.8.2.8. US Cardiac Resynchronization Therapy Market Volume and Forecasts Analysis – By Type (‘000 Units)
9.8.3. US Congestive Heart Failure (CHF) Treatment Devices Market Revenue Forecasts and Analysis - By End User (US$ MN)
9.9. CANADA MARKET OVERVIEW
9.9.1. Canada Congestive Heart Failure (CHF) Treatment Devices Market Revenue Forecasts and Analysis - By Product (US$ Mn)
9.9.2. Canada Congestive Heart Failure (CHF) Treatment Devices Market Volume Forecasts and Analysis - By Product (‘000 Units)
9.9.2.1. Canada Ventricular Assist Devices (VADs) Market Revenue and Forecasts Analysis – By Type (US$ Mn)
9.9.2.2. Canada Ventricular Assist Devices (VADs) Market Volume and Forecasts Analysis – By Type (‘000 Units)
9.9.2.3. Canada Implantable Cardioverter Defibrillators Market Revenue and Forecasts Analysis – By Type (US$ Mn)
9.9.2.4. Canada Implantable Cardioverter Defibrillators Market Volume and Forecasts Analysis – By Type (‘000 Units)
9.9.2.5. Canada Pacemakers Market Revenue and Forecasts Analysis – By Type (US$ Mn)
9.9.2.6. Canada Pacemakers Market Volume and Forecasts Analysis – By Type (‘000 Units)
9.9.2.7. Canada Cardiac Resynchronization Therapy Market Revenue and Forecasts Analysis – By Type (US$ Mn)
9.9.2.8. Canada Cardiac Resynchronization Therapy Market Volume and Forecasts Analysis – By Type (‘000 Units)
9.9.3. Canada Congestive Heart Failure (CHF) Treatment Devices Market Revenue Forecasts and Analysis - By End User (US$ Mn)
9.10. MEXICO MARKET OVERVIEW
9.10.1. Mexico Congestive Heart Failure (CHF) Treatment Devices Market Revenue Forecasts and Analysis - By Product (US$ Mn)
9.10.2. Mexico Congestive Heart Failure (CHF) Treatment Devices Market Volume Forecasts and Analysis - By Product (‘000 Units)
9.10.2.1. Mexico Ventricular Assist Devices (VADs) Market Revenue and Forecasts Analysis – By Type (US$ Mn)
9.10.2.2. Mexico Ventricular Assist Devices (VADs) Market Volume and Forecasts Analysis – By Type (‘000 Units)
9.10.2.3. Mexico Implantable Cardioverter Defibrillators Market Revenue and Forecasts Analysis – By Type (US$ Mn)
9.10.2.4. Mexico Implantable Cardioverter Defibrillators Market Volume and Forecasts Analysis – By Type (‘000 Units)
9.10.2.5. Mexico Pacemakers Market Revenue and Forecasts Analysis – By Type (US$ Mn)
9.10.2.6. Mexico Pacemakers Market Volume and Forecasts Analysis – By Type (‘000 Units)
9.10.2.7. Mexico Cardiac Resynchronization Therapy Market Revenue and Forecasts Analysis – By Type (US$ Mn)
9.10.2.8. Mexico Cardiac Resynchronization Therapy Market Volume and Forecasts Analysis – By Type (‘000 Units)
9.10.3. Mexico Congestive Heart Failure (CHF) Treatment Devices Market Revenue Forecasts and Analysis - By End User (US$ Mn)

10. EUROPE CONGESTIVE HEART FAILURE (CHF) TREATMENT DEVICES MARKET REVENUE AND FORECASTS TO 2025 – COUNTRY ANALYSIS
10.1. EUROPE CONGESTIVE HEART FAILURE (CHF) TREATMENT DEVICES MARKET OVERVIEW
10.2. EUROPE CONGESTIVE HEART FAILURE (CHF) TREATMENT DEVICES MARKET REVENUE FORECASTS AND ANALYSIS (US$ MN)
10.3. EUROPE CONGESTIVE HEART FAILURE (CHF) TREATMENT DEVICES MARKET VOLUME FORECASTS AND ANALYSIS (‘000 UNITS)
10.4. EUROPE CONGESTIVE HEART FAILURE (CHF) TREATMENT DEVICES MARKET REVENUE AND FORECASTS ANALYSIS – BY PRODUCT (US$ MN)
10.5. EUROPE CONGESTIVE HEART FAILURE (CHF) TREATMENT DEVICES MARKET VOLUME AND FORECASTS ANALYSIS – BY PRODUCT (‘000 UNITS)
10.5.1. Europe Ventricular Assist Devices (VADS) Market Revenue and Forecasts Analysis – By Type (US$ Mn)
10.5.2. Europe Ventricular Assist Devices (VADS) Market Volume and Forecasts Analysis – By Type (‘000 Units)
10.5.3. Europe Implantable Cardioverter Defibrillators Market Revenue and Forecasts Analysis – By Type (US$ Mn)
10.5.4. Europe Implantable Cardioverter Defibrillators Market Volume and Forecasts Analysis – By Type (‘000 Units)
10.5.5. Europe Pacemakers Market Revenue and Forecasts Analysis – By Type (Us$ Mn)
10.5.6. Europe Pacemakers Market Volume and Forecasts Analysis – By Type (‘000 Units)
10.5.7. Europe Cardiac Resynchronization Therapy Market Revenue and Forecasts Analysis – By Type (Us$ Mn)
10.5.8. Europe Cardiac Resynchronization Therapy Market Volume and Forecasts Analysis – By Type (‘000 Units)
10.6. EUROPE CONGESTIVE HEART FAILURE (CHF) TREATMENT DEVICES MARKET REVENUE AND FORECASTS ANALYSIS – BY END USER (US$ MN)
10.7. EUROPE CONGESTIVE HEART FAILURE (CHF) TREATMENT DEVICES MARKET REVENUE AND FORECASTS ANALYSIS – BY COUNTRY (US$ MN)
10.8. UK MARKET OVERVIEW
10.8.1. UK Congestive Heart Failure (CHF) Treatment Devices Market Revenue Forecasts and Analysis - By Product (US$ Mn)
10.8.2. UK Congestive Heart Failure (CHF) Treatment Devices Market Volume Forecasts and Analysis - By Product (‘000 Units)
10.8.2.1. UK Ventricular Assist Devices (VADs) Market Revenue and Forecasts Analysis – By Type (US$ Mn)
10.8.2.2. UK Ventricular Assist Devices (VADs) Market Volume and Forecasts Analysis – By Type (‘000 Units)
10.8.2.3. UK Implantable Cardioverter Defibrillators Market Revenue and Forecasts Analysis – By Type (US$ Mn)
10.8.2.4. UK Implantable Cardioverter Defibrillators Market Volume and Forecasts Analysis – By Type (‘000 Units)
10.8.2.5. UK Pacemakers Market Revenue and Forecasts Analysis – By Type (US$ Mn)
10.8.2.6. UK Pacemakers Market Volume and Forecasts Analysis – By Type (‘000 Units)
10.8.2.7. UK Cardiac Resynchronization Therapy Market Revenue and Forecasts Analysis – By Type (US$ Mn)
10.8.2.8. UK Cardiac Resynchronization Therapy Market Volume and Forecasts Analysis – By Type (‘000 Units)
10.8.3. UK Congestive Heart Failure (CHF) Treatment Devices Market Revenue Forecasts and Analysis - By End User (US$ Mn)
10.9. GERMANY MARKET OVERVIEW
10.9.1. Germany Congestive Heart Failure (CHF) Treatment Devices Market Revenue Forecasts and Analysis - By Product (US$ Mn)
10.9.2. Germany Congestive Heart Failure (CHF) Treatment Devices Market Volume Forecasts and Analysis - By Product (‘000 Units)
10.9.2.1. Germany Ventricular Assist Devices (VADs) Market Revenue and Forecasts Analysis – By Type (US$ Mn)
10.9.2.2. Germany Ventricular Assist Devices (VADs) Market Volume and Forecasts Analysis – By Type (‘000 Units)
10.9.2.3. Germany Implantable Cardioverter Defibrillators Market Revenue and Forecasts Analysis – By Type (US$ Mn)
10.9.2.4. Germany Implantable Cardioverter Defibrillators Market Volume and Forecasts Analysis – By Type (‘000 Units)
10.9.2.5. Germany Pacemakers Market Revenue and Forecasts Analysis – By Type (US$ Mn)
10.9.2.6. Germany Pacemakers Market Volume and Forecasts Analysis – By Type (‘000 Units)
10.9.2.7. Germany Cardiac Resynchronization Therapy Market Revenue and Forecasts Analysis – By Type (US$ Mn)
10.9.2.8. Germany Cardiac Resynchronization Therapy Market Volume and Forecasts Analysis – By Type (‘000 Units)
10.9.3. Germany Congestive Heart Failure (CHF) Treatment Devices Market Revenue Forecasts and Analysis - By End User (US$ Mn)
10.10. FRANCE MARKET OVERVIEW
10.10.1. France Congestive Heart Failure (CHF) Treatment Devices Market Revenue Forecasts and Analysis - By Product (US$ Mn)
10.10.2. France Congestive Heart Failure (CHF) Treatment Devices Market Volume Forecasts and Analysis - By Product (‘000 Units)
10.10.2.1. France Ventricular Assist Devices (VADs) Market Revenue and Forecasts Analysis – By Type (US$ Mn)
10.10.2.2. France Ventricular Assist Devices (VADs) Market Volume and Forecasts Analysis – By Type (‘000 Units)
10.10.2.3. France Implantable Cardioverter Defibrillators Market Revenue and Forecasts Analysis – By Type (US$ Mn)
10.10.2.4. France Implantable Cardioverter Defibrillators Market Volume and Forecasts Analysis – By Type (‘000 Units)
10.10.2.5. France Pacemakers Market Revenue and Forecasts Analysis – By Type (US$ Mn)
10.10.2.6. France Pacemakers Market Volume and Forecasts Analysis – By Type (‘000 Units)
10.10.2.7. France Cardiac Resynchronization Therapy Market Revenue and Forecasts Analysis – By Type (US$ Mn)
10.10.2.8. France Cardiac Resynchronization Therapy Market Volume and Forecasts Analysis – By Type (‘000 Units)
10.10.3. France Congestive Heart Failure (CHF) Treatment Devices Market Revenue Forecasts and Analysis - By End User (US$ Mn)

11. ASIA PACIFIC CONGESTIVE HEART FAILURE (CHF) TREATMENT DEVICES MARKET REVENUE AND FORECASTS TO 2025 – COUNTRY ANALYSIS
11.1. ASIA PACIFIC CONGESTIVE HEART FAILURE (CHF) TREATMENT DEVICES MARKET OVERVIEW
11.2. ASIA PACIFIC CONGESTIVE HEART FAILURE (CHF) TREATMENT DEVICES MARKET REVENUE FORECASTS AND ANALYSIS (US$ MN)
11.3. ASIA PACIFIC CONGESTIVE HEART FAILURE (CHF) TREATMENT DEVICES MARKET VOLUME FORECASTS AND ANALYSIS (‘000 UNITS)
11.4. ASIA PACIFIC CONGESTIVE HEART FAILURE (CHF) TREATMENT DEVICES MARKET REVENUE AND FORECASTS ANALYSIS – BY PRODUCT (US$ MN)
11.5. ASIA PACIFIC CONGESTIVE HEART FAILURE (CHF) TREATMENT DEVICES MARKET VOLUME AND FORECASTS ANALYSIS – BY PRODUCT (‘000 UNITS)
11.5.1. Asia Pacific Ventricular Assist Devices (VADS) Market Revenue and Forecasts Analysis – By Type (US$ Mn)
11.5.2. Asia Pacific Ventricular Assist Devices (VADS) Market Volume and Forecasts Analysis – By Type (‘000 Units)
11.5.3. Asia Pacific Implantable Cardioverter Defibrillators Market Revenue and Forecasts Analysis – By Type (US$ Mn)
11.5.4. Asia Pacific Implantable Cardioverter Defibrillators Market Volume and Forecasts Analysis – By Type (‘000 Units)
11.5.5. Asia Pacific Pacemakers Market Revenue and Forecasts Analysis – By Type (Us$ Mn)
11.5.6. Asia Pacific Pacemakers Market Volume and Forecasts Analysis – By Type (‘000 Units)
11.5.7. Asia Pacific Cardiac Resynchronization Therapy Market Revenue and Forecasts Analysis – By Type (Us$ Mn)
11.5.8. Asia Pacific Cardiac Resynchronization Therapy Market Volume and Forecasts Analysis – By Type (‘000 Units)
11.6. ASIA PACIFIC CONGESTIVE HEART FAILURE (CHF) TREATMENT DEVICES MARKET REVENUE AND FORECASTS ANALYSIS – BY END USER (US$ MN)
11.7. ASIA PACIFIC CONGESTIVE HEART FAILURE (CHF) TREATMENT DEVICES MARKET REVENUE AND FORECASTS ANALYSIS – BY COUNTRY (US$ MN)
11.8. JAPAN MARKET OVERVIEW
11.8.1. Japan Congestive Heart Failure (CHF) Treatment Devices Market Revenue Forecasts and Analysis - By Product (US$ Mn)
11.8.2. Japan Congestive Heart Failure (CHF) Treatment Devices Market Volume Forecasts and Analysis - By Product (‘000 Units)
11.8.2.1. Japan Ventricular Assist Devices (VADs) Market Revenue and Forecasts Analysis – By Type (US$ Mn)
11.8.2.2. Japan Ventricular Assist Devices (VADs) Market Volume and Forecasts Analysis – By Type (‘000 Units)
11.8.2.3. Japan Implantable Cardioverter Defibrillators Market Revenue and Forecasts Analysis – By Type (US$ Mn)
11.8.2.4. Japan Implantable Cardioverter Defibrillators Market Volume and Forecasts Analysis – By Type (‘000 Units)
11.8.2.5. Japan Pacemakers Market Revenue and Forecasts Analysis – By Type (US$ Mn)
11.8.2.6. Japan Pacemakers Market Volume and Forecasts Analysis – By Type (‘000 Units)
11.8.2.7. Japan Cardiac Resynchronization Therapy Market Revenue and Forecasts Analysis – By Type (US$ Mn)
11.8.2.8. Japan Cardiac Resynchronization Therapy Market Volume and Forecasts Analysis – By Type (‘000 Units)
11.8.3. Japan Congestive Heart Failure (CHF) Treatment Devices Market Revenue Forecasts and Analysis - By End User (US$ Mn)
11.9. CHINA MARKET OVERVIEW
11.9.1. China Congestive Heart Failure (CHF) Treatment Devices Market Revenue Forecasts and Analysis - By Product (US$ Mn)
11.9.2. China Congestive Heart Failure (CHF) Treatment Devices Market Volume Forecasts and Analysis - By Product (‘000 Units)
11.9.2.1. China Ventricular Assist Devices (VADs) Market Revenue and Forecasts Analysis – By Type (US$ Mn)
11.9.2.2. China Ventricular Assist Devices (VADs) Market Volume and Forecasts Analysis – By Type (‘000 Units)
11.9.2.3. China Implantable Cardioverter Defibrillators Market Revenue and Forecasts Analysis – By Type (US$ Mn)
11.9.2.4. China Implantable Cardioverter Defibrillators Market Volume and Forecasts Analysis – By Type (‘000 Units)
11.9.2.5. China Pacemakers Market Revenue and Forecasts Analysis – By Type (US$ Mn)
11.9.2.6. China Pacemakers Market Volume and Forecasts Analysis – By Type (‘000 Units)
11.9.2.7. China Cardiac Resynchronization Therapy Market Revenue and Forecasts Analysis – By Type (US$ Mn)
11.9.2.8. China Cardiac Resynchronization Therapy Market Volume and Forecasts Analysis – By Type (‘000 Units)
11.9.3. China Congestive Heart Failure (CHF) Treatment Devices Market Revenue Forecasts and Analysis - By End User (US$ Mn)
11.10. INDIA MARKET OVERVIEW
11.10.1. India Congestive Heart Failure (CHF) Treatment Devices Market Revenue Forecasts and Analysis - By Product (US$ Mn)
11.10.2. India Congestive Heart Failure (CHF) Treatment Devices Market Volume Forecasts and Analysis - By Product (‘000 Units)
11.10.2.1. India Ventricular Assist Devices (VADs) Market Revenue and Forecasts Analysis – By Type (US$ Mn)
11.10.2.2. India Ventricular Assist Devices (VADs) Market Volume and Forecasts Analysis – By Type (‘000 Units)
11.10.2.3. India Implantable Cardioverter Defibrillators Market Revenue and Forecasts Analysis – By Type (US$ Mn)
11.10.2.4. India Implantable Cardioverter Defibrillators Market Volume and Forecasts Analysis – By Type (‘000 Units)
11.10.2.5. India Pacemakers Market Revenue and Forecasts Analysis – By Type (US$ Mn)
11.10.2.6. India Pacemakers Market Volume and Forecasts Analysis – By Type (‘000 Units)
11.10.2.7. India Cardiac Resynchronization Therapy Market Revenue and Forecasts Analysis – By Type (US$ Mn)
11.10.2.8. India Cardiac Resynchronization Therapy Market Volume and Forecasts Analysis – By Type (‘000 Units)
11.10.3. India Congestive Heart Failure (CHF) Treatment Devices Market Revenue Forecasts and Analysis - By End User (US$ Mn)

12. MIDDLE EAST AND AFRICA (MEA) CONGESTIVE HEART FAILURE (CHF) TREATMENT DEVICES MARKET REVENUE AND FORECASTS TO 2025 – COUNTRY ANALYSIS
12.1. MIDDLE EAST AND AFRICA CONGESTIVE HEART FAILURE (CHF) TREATMENT DEVICES MARKET OVERVIEW
12.2. MIDDLE EAST AND AFRICA CONGESTIVE HEART FAILURE (CHF) TREATMENT DEVICES MARKET REVENUE FORECASTS AND ANALYSIS (US$ MN)
12.3. MIDDLE EAST AND AFRICA CONGESTIVE HEART FAILURE (CHF) TREATMENT DEVICES MARKET VOLUME FORECASTS AND ANALYSIS (‘000 UNITS)
12.4. MIDDLE EAST AND AFRICA CONGESTIVE HEART FAILURE (CHF) TREATMENT DEVICES MARKET REVENUE AND FORECASTS ANALYSIS – BY PRODUCT (US$ MN)
12.5. MIDDLE EAST AND AFRICA CONGESTIVE HEART FAILURE (CHF) TREATMENT DEVICES MARKET VOLUME AND FORECASTS ANALYSIS – BY PRODUCT (‘000 UNITS)
12.5.1. Middle East and Africa America Ventricular Assist Devices (VADS) Market Revenue and Forecasts Analysis – By Type (US$ Mn)
12.5.2. Middle East and Africa America Ventricular Assist Devices (VADS) Market Volume and Forecasts Analysis – By Type (‘000 Units)
12.5.3. Middle East and Africa America Implantable Cardioverter Defibrillators Market Revenue and Forecasts Analysis – By Type (US$ Mn)
12.5.4. Middle East and Africa America Implantable Cardioverter Defibrillators Market Volume and Forecasts Analysis – By Type (‘000 Units)
12.5.5. Middle East and Africa America Pacemakers Market Revenue and Forecasts Analysis – By Type (Us$ Mn)
12.5.6. Middle East and Africa America Pacemakers Market Volume and Forecasts Analysis – By Type (‘000 Units)
12.5.7. Middle East and Africa America Cardiac Resynchronization Therapy Market Revenue and Forecasts Analysis – By Type (Us$ Mn)
12.5.8. Middle East and Africa America Cardiac Resynchronization Therapy Market Volume and Forecasts Analysis – By Type (‘000 Units)
12.6. MIDDLE EAST AND AFRICA CONGESTIVE HEART FAILURE (CHF) TREATMENT DEVICES MARKET REVENUE AND FORECASTS ANALYSIS – BY END USER (US$ MN)
12.7. MIDDLE EAST AND AFRICA CONGESTIVE HEART FAILURE (CHF) TREATMENT DEVICES MARKET REVENUE AND FORECASTS ANALYSIS – BY COUNTRY (US$ MN)
12.8. SOUTH AFRICA MARKET OVERVIEW
12.8.1. South Africa Congestive Heart Failure (CHF) Treatment Devices Market Revenue Forecasts and Analysis - By Product (US$ Mn)
12.8.2. South Africa Congestive Heart Failure (CHF) Treatment Devices Market Volume Forecasts and Analysis - By Product (‘000 Units)
12.8.2.1. South Africa Ventricular Assist Devices (VADs) Market Revenue and Forecasts Analysis – By Type (US$ Mn)
12.8.2.2. South Africa Ventricular Assist Devices (VADs) Market Volume and Forecasts Analysis – By Type (‘000 Units)
12.8.2.3. South Africa Implantable Cardioverter Defibrillators Market Revenue and Forecasts Analysis – By Type (US$ Mn)
12.8.2.4. South Africa Implantable Cardioverter Defibrillators Market Volume and Forecasts Analysis – By Type (‘000 Units)
12.8.2.5. South Africa Pacemakers Market Revenue and Forecasts Analysis – By Type (US$ Mn)
12.8.2.6. South Africa Pacemakers Market Volume and Forecasts Analysis – By Type (‘000 Units)
12.8.2.7. South Africa Cardiac Resynchronization Therapy Market Revenue and Forecasts Analysis – By Type (US$ Mn)
12.8.2.8. South Africa Cardiac Resynchronization Therapy Market Volume and Forecasts Analysis – By Type (‘000 Units)
12.8.3. South Africa Congestive Heart Failure (CHF) Treatment Devices Market Revenue Forecasts and Analysis - By End User (US$ Mn)
12.9. SAUDI ARABIA MARKET OVERVIEW
12.9.1. Saudi Arabia Congestive Heart Failure (CHF) Treatment Devices Market Revenue Forecasts and Analysis - By Product (US$ Mn)
12.9.2. Saudi Arabia Congestive Heart Failure (CHF) Treatment Devices Market Volume Forecasts and Analysis - By Product (‘000 Units)
12.9.2.1. Saudi Arabia Ventricular Assist Devices (VADs) Market Revenue and Forecasts Analysis – By Type (US$ Mn)
12.9.2.2. Saudi Arabia Ventricular Assist Devices (VADs) Market Volume and Forecasts Analysis – By Type (‘000 Units)
12.9.2.3. Saudi Arabia Implantable Cardioverter Defibrillators Market Revenue and Forecasts Analysis – By Type (US$ Mn)
12.9.2.4. Saudi Arabia Implantable Cardioverter Defibrillators Market Volume and Forecasts Analysis – By Type (‘000 Units)
12.9.2.5. Saudi Arabia Pacemakers Market Revenue and Forecasts Analysis – By Type (US$ Mn)
12.9.2.6. Saudi Arabia Pacemakers Market Volume and Forecasts Analysis – By Type (‘000 Units)
12.9.2.7. Saudi Arabia Cardiac Resynchronization Therapy Market Revenue and Forecasts Analysis – By Type (US$ Mn)
12.9.2.8. Saudi Arabia Cardiac Resynchronization Therapy Market Volume and Forecasts Analysis – By Type (‘000 Units)
12.9.3. Saudi Arabia Congestive Heart Failure (CHF) Treatment Devices Market Revenue Forecasts and Analysis - By End User (US$ Mn)
12.10. UAE MARKET OVERVIEW
12.10.1. UAE Congestive Heart Failure (CHF) Treatment Devices Market Revenue Forecasts and Analysis - By Product (US$ Mn)
12.10.2. UAE Congestive Heart Failure (CHF) Treatment Devices Market Volume Forecasts and Analysis - By Product (‘000 Units)
12.10.2.1. UAE Ventricular Assist Devices (VADs) Market Revenue and Forecasts Analysis – By Type (US$ Mn)
12.10.2.2. UAE Ventricular Assist Devices (VADs) Market Volume and Forecasts Analysis – By Type (‘000 Units)
12.10.2.3. UAE Implantable Cardioverter Defibrillators Market Revenue and Forecasts Analysis – By Type (US$ Mn)
12.10.2.4. UAE Implantable Cardioverter Defibrillators Market Volume and Forecasts Analysis – By Type (‘000 Units)
12.10.2.5. UAE Pacemakers Market Revenue and Forecasts Analysis – By Type (US$ Mn)
12.10.2.6. UAE Pacemakers Market Volume and Forecasts Analysis – By Type (‘000 Units)
12.10.2.7. UAE Cardiac Resynchronization Therapy Market Revenue and Forecasts Analysis – By Type (US$ Mn)
12.10.2.8. UAE Cardiac Resynchronization Therapy Market Volume and Forecasts Analysis – By Type (‘000 Units)
12.10.3. UAE Congestive Heart Failure (CHF) Treatment Devices Market Revenue Forecasts and Analysis - By End User (US$ Mn)

13. SOUTH AND CENTRAL AMERICA CONGESTIVE HEART FAILURE (CHF) TREATMENT DEVICES MARKET REVENUE AND FORECASTS TO 2025 – COUNTRY ANALYSIS
13.1. SOUTH AND CENTRAL AMERICA CONGESTIVE HEART FAILURE (CHF) TREATMENT DEVICES MARKET OVERVIEW
13.2. SOUTH AND CENTRAL AMERICA CONGESTIVE HEART FAILURE (CHF) TREATMENT DEVICES MARKET REVENUE FORECASTS AND ANALYSIS (US$ MN)
13.3. SOUTH AND CENTRAL AMERICA CONGESTIVE HEART FAILURE (CHF) TREATMENT DEVICES MARKET VOLUME FORECASTS AND ANALYSIS (‘000 UNITS)
13.4. SOUTH AND CENTRAL AMERICA CONGESTIVE HEART FAILURE (CHF) TREATMENT DEVICES MARKET REVENUE AND FORECASTS ANALYSIS – BY PRODUCT (US$ MN)
13.5. SOUTH AND CENTRAL AMERICA CONGESTIVE HEART FAILURE (CHF) TREATMENT DEVICES MARKET VOLUME AND FORECASTS ANALYSIS – BY PRODUCT (‘000 UNITS)
13.5.1. South and Central America Ventricular Assist Devices (VADS) Market Revenue and Forecasts Analysis – By Type (US$ Mn)
13.5.2. South and Central America Ventricular Assist Devices (VADS) Market Volume and Forecasts Analysis – By Type (‘000 Units)
13.5.3. South and Central America Implantable Cardioverter Defibrillators Market Revenue and Forecasts Analysis – By Type (US$ Mn)
13.5.4. South and Central America Implantable Cardioverter Defibrillators Market Volume and Forecasts Analysis – By Type (‘000 Units)
13.5.5. South and Central America Pacemakers Market Revenue and Forecasts Analysis – By Type (Us$ Mn)
13.5.6. South and Central America Pacemakers Market Volume and Forecasts Analysis – By Type (‘000 Units)
13.5.7. South and Central America Cardiac Resynchronization Therapy Market Revenue and Forecasts Analysis – By Type (Us$ Mn)
13.5.8. South and Central America Cardiac Resynchronization Therapy Market Volume and Forecasts Analysis – By Type (‘000 Units)
13.6. SOUTH AND CENTRAL AMERICA CONGESTIVE HEART FAILURE (CHF) TREATMENT DEVICES MARKET REVENUE AND FORECASTS ANALYSIS – BY END USER (US$ MN)
13.7. SOUTH AND CENTRAL AMERICA CONGESTIVE HEART FAILURE (CHF) TREATMENT DEVICES MARKET REVENUE AND FORECASTS ANALYSIS – BY COUNTRY (US$ MN)
13.8. BRAZIL MARKET OVERVIEW
13.8.1. Brazil Congestive Heart Failure (CHF) Treatment Devices Market Revenue Forecasts and Analysis - By Product (US$ Mn)
13.8.2. Brazil Congestive Heart Failure (CHF) Treatment Devices Market Volume Forecasts and Analysis - By Product (‘000 Units)
13.8.2.1. Brazil Ventricular Assist Devices (VADs) Market Revenue and Forecasts Analysis – By Type (US$ Mn)
13.8.2.2. Brazil Ventricular Assist Devices (VADs) Market Volume and Forecasts Analysis – By Type (‘000 Units)
13.8.2.3. Brazil Implantable Cardioverter Defibrillators Market Revenue and Forecasts Analysis – By Type (US$ Mn)
13.8.2.4. Brazil Implantable Cardioverter Defibrillators Market Volume and Forecasts Analysis – By Type (‘000 Units)
13.8.2.5. Brazil Pacemakers Market Revenue and Forecasts Analysis – By Type (US$ Mn)
13.8.2.6. Brazil Pacemakers Market Volume and Forecasts Analysis – By Type (‘000 Units)
13.8.2.7. Brazil Cardiac Resynchronization Therapy Market Revenue and Forecasts Analysis – By Type (US$ Mn)
13.8.2.8. Brazil Cardiac Resynchronization Therapy Market Volume and Forecasts Analysis – By Type (‘000 Units)
13.8.3. Brazil Congestive Heart Failure (CHF) Treatment Devices Market Revenue Forecasts and Analysis - By End User (US$ Mn)

14. INDUSTRY LANDSCAPE
14.1. ORGANIC GROWTH STRATEGIES
14.1.1. New Product Launches
14.1.2. Marketing & Promotional Activities
14.2. INORGANIC GROWTH STRATEGIES
14.2.1. Partnerships, Collaborations, And Joint Ventures
14.2.2. Mergers & Acquisitions
15. CONGESTIVE HEART FAILURE (CHF) TREATMENT DEVICES MARKET, KEY COMPANY PROFILES
15.1. GENERAL ELECTRIC COMPANY
15.1.1. Key Facts
15.1.2. Business Description
15.1.3. Financial Overview
15.1.4. Product Portfolio
15.1.5. Product Pipeline
15.1.6. SWOT Analysis
15.1.7. Key Developments
15.2. SIEMENS HEALTHCARE GMBH
15.2.1. Key Facts
15.2.2. Business Description
15.2.3. Financial Overview
15.2.4. Product Portfolio
15.2.5. Product Pipeline
15.2.6. SWOT Analysis
15.2.7. Key Developments
15.3. KONINKLIJKE PHILIPS N.V.
15.3.1. Key Facts
15.3.2. Business Description
15.3.3. Financial Overview
15.3.4. Product Portfolio
15.3.5. Product Portfolio
15.3.6. SWOT Analysis
15.3.7. Key Developments

15.4. MEDTRONIC
15.4.1. Key Facts
15.4.2. Business Description
15.4.3. Financial Overview
15.4.4. Product Portfolio
15.4.5. Product Pipeline
15.4.6. SWOT Analysis
15.4.7. Key Developments
15.5. SAMSUNGHEALTHCARE.COM
15.5.1. Key Facts
15.5.2. Business Description
15.5.3. Financial Overview
15.5.4. Product Portfolio
15.5.5. Product Portfolio
15.5.6. SWOT Analysis
15.5.7. Key Developments
15.6. TOSHIBA CORPORATION.
15.6.1. Key Facts
15.6.2. Business Description
15.6.3. Financial Overview
15.6.4. Product Portfolio
15.6.5. Product Portfolio
15.6.6. SWOT Analysis
15.6.7. Key Developments
15.7. KONING CORPORATION
15.7.1. Key Facts
15.7.2. Business Description
15.7.3. Financial Overview
15.7.4. Product Portfolio
15.7.5. Product Pipeline
15.7.6. SWOT Analysis
15.7.7. Key Developments
15.8. CARESTREAM HEALTH
15.8.1. Key Facts
15.8.2. Business Description
15.8.3. Financial Overview
15.8.4. Product Portfolio
15.8.5. Product Pipeline
15.8.6. SWOT Analysis
15.8.7. Key Developments
15.9. PLANMED OY
15.9.1. Key Facts
15.9.2. Business Description
15.9.3. Financial Overview
15.9.4. Product Portfolio
15.9.5. Product Pipeline
15.9.6. SWOT Analysis
15.9.7. Key Developments
15.10. HITACHI, LTD.
15.10.1. Key Facts
15.10.2. Business Description
15.10.3. Financial Overview
15.10.4. Product Portfolio
15.10.5. Product Pipeline
15.10.6. SWOT Analysis
15.10.7. Key Developments

16. APPENDIX
16.1. ABOUT THE INSIGHT PARTNERS
16.2. GLOSSARY OF TERMS
16.3. RESEARCH METHODOLOGY

The List of Companies

1. Medtronic
2. Boston Scientific Corporation
3. Biotronik
4. St. Jude Medical
5. Micromed AS
6. LivaNova
7. ABIOMED
8. HeartWare International, Inc.
9. Jarvik Heart, Inc.
10. Berlin Heart

Select License Type
USD $4550
USD $6550
USD $8550

Free

20%

customization on Pre-Booking
Pre Book